Biopharmaceutical Contract Manufacturing / Biomanufacturing Services

Ensera LDB 9-9-2026
Monday, August 31, 2026
read more
Accelerating European market entry for Asia-manufactured biosimilars
Monday, August 31, 2026
Learn how Ensera can help deliver a cold chain–enabled solution designed for agility, complexity and accelerated market entry. read more
Supporting ultra-low-volume orphan drug launches with complex secondary packaging
Monday, August 31, 2026
Discover how Ensera provided an orphan drug customer with flexible secondary packaging, labeling, and kitting for highly specialized injectable products in very low volumes. read more
When commercialization doesn't follow a standard playbook
Monday, August 31, 2026
Low-volume launches. Complex combination products. Market-specific requirements. Unpredictable demand. Commercialization challenges are different for every program, yet many outsourcing models are built for standardization, not flexibility.
Discover how Ensera helps pharmaceutical companies ... read more
Enabling smooth, dual-market delivery of a kitted PFS biosimilar requiring terminal sterilization
Monday, August 31, 2026
Learn how Ensera helps global biosimilar companies by providing agile capacity, sterile packaging advice, and sterilization management to support a smooth and timely launch in Europe, while preparing the program for future expansion into North America. read more

Disabled_Documentary: A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...